Cite
Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up.
MLA
Weiss, Margaret Danielle, et al. “Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up.” Journal of Child and Adolescent Psychopharmacology, vol. 31, no. 9, Nov. 2021, pp. 623–30. EBSCOhost, https://doi.org/10.1089/cap.2021.0087.
APA
Weiss, M. D., Surman, C., Khullar, A., Owens, J., He, E., Cataldo, M., & Donnelly, G. (2021). Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up. Journal of Child and Adolescent Psychopharmacology, 31(9), 623–630. https://doi.org/10.1089/cap.2021.0087
Chicago
Weiss, Margaret Danielle, Craig Surman, Atul Khullar, Judith Owens, Ellie He, Marc Cataldo, and Graeme Donnelly. 2021. “Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up.” Journal of Child and Adolescent Psychopharmacology 31 (9): 623–30. doi:10.1089/cap.2021.0087.